Lataa...
Impact of granulocyte colony‐stimulating factor on FOLFIRINOX‐induced neutropenia prevention: A population pharmacokinetic/pharmacodynamic approach
AIMS: Granulocyte colony‐stimulating factor (G‐CSF) is frequently prescribed to prevent chemotherapy‐induced neutropenia, but the administration schedule remains empirical in case of bimonthly chemotherapy such as FOLFIRINOX regimen. This pharmacokinetic/pharmacodynamic (PK/PD) study was performed t...
Tallennettuna:
| Julkaisussa: | Br J Clin Pharmacol |
|---|---|
| Päätekijät: | , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
John Wiley and Sons Inc.
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7688541/ https://ncbi.nlm.nih.gov/pubmed/32386071 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.14356 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|